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The biological response to DNA double-strand breaks
acts to preserve genome integrity. Individuals bearing
inactivatingmutations in componentsof this response
exhibit clinical symptoms that include cellular radio-
sensitivity, immunodeficiency, andcancerpredisposi-
tion. The archetype for suchdisorders is Ataxia-Telan-
giectasiacausedbybiallelicmutation inATM, a central
component of the DNA damage response. Here, we
report that the ubiquitin ligase RNF168 is mutated in
theRIDDLEsyndrome,a recentlydiscovered immuno-
deficiency and radiosensitivity disorder.Weshow that
RNF168 is recruited tositesofDNAdamagebybinding
toubiquitylatedhistoneH2A.RNF168actswithUBC13
to amplify the RNF8-dependent histone ubiquitylation
by targeting H2A-type histones and by promoting the
formation of lysine 63-linked ubiquitin conjugates.
These RNF168-dependent chromatin modifications
orchestrate the accumulation of 53BP1 and BRCA1
to DNA lesions, and their loss is the likely cause of
the cellular and developmental phenotypes associ-
ated with RIDDLE syndrome.
INTRODUCTION
DNA damage, signaling, and repair are fundamental processes
required to maintain cellular viability and homeostasis. Among
the different types of DNA lesions, the DNA double-strand break
(DSB) is considered the most harmful. Indeed, unrepaired DSBs
can be lethal to the cell, and their inaccurate repair leads to chro-
mosomal rearrangements that promote tumorigenesis (Jeggo
and Lobrich, 2007). Defects in DSB repair are also associated
with accelerated aging, exhaustion of stem cell pools, infertility,
and impaired development of the nervous and immune systems
(Callen et al., 2007; McKinnon and Caldecott, 2007). Therefore,420 Cell 136, 420–434, February 6, 2009 ª2009 Elsevier Inc.to counteract these unwanted outcomes, DSBs elicit a complex
response that promotes DNA repair and profoundly influences
multiple aspects of cellular physiology (JeggoandLobrich, 2007).
Germline mutations in genes coding for regulators of the DSB
response are responsible for complex diseases that have a wide
range of clinical phenotypes. A paradigm for such syndromes is
Ataxia-Telangiectasia (A-T) caused by biallelicmutations inATM,
which encodes a serine/threonine kinase of the PI(3) kinase-like
kinases family (Savitsky et al., 1995). Loss of ATM results in
progressive neurodegeneration, immune dysfunction, hypersen-
sitivity to ionizing radiation (IR), and marked predisposition to
cancer (Lavin and Shiloh, 1997). At the cellular level, ATM is at the
hub of the response to DSBs. ATM rapidly accumulates at DNA
lesions in a MRE11/RAD50/NBS1 (MRN)-dependent manner to
initiate a cascade of protein recruitment at sites of DNA damage
(Bekker-Jensen et al., 2006). This chromatin-based cascade
promotes DNA repair and activation of cell-cycle checkpoints,
two critical outcomes of the DNA damage response. The accumu-
lation of proteins at DSB sites produces characteristic subnuclear
foci that are easily visualized by fluorescence microscopy.
ATM promotes the relocalization of many repair and signaling
proteins at DNA breaks largely via the phosphorylation of the
histone H2A variant H2AX on Ser139 (Rogakou et al., 1998; Stiff
et al., 2004). H2AX phosphorylation (referred to as g-H2AX)
establishes a chromatin domain onto which regulators of the
DSB response accumulate. In particular, the g-H2AX phosphoe-
pitope is directly recognized by the BRCT domains of the medi-
ator protein MDC1 (Lou et al., 2006; Stewart et al., 2003; Stucki
et al., 2005). MDC1 acts as a molecular scaffold that stabilizes
the MRN complex bound to damaged chromatin while
promoting further accumulation of MRN and activated ATM.
MDC1, therefore, amplifies the ATM-dependent DNA damage
response (Lou et al., 2006; Stucki et al., 2005).
MDC1 is also phosphorylated by ATMon ‘‘TQXF’’motifs (Huen
et al., 2007; Kolas et al., 2007; Matsuoka et al., 2007) that
promote the recruitment of RNF8, an E3 ubiquitin ligase (Huen
et al., 2007; Kolas et al., 2007; Mailand et al., 2007; Plans
et al., 2006). RNF8, in turn, independently stimulates the
recruitment of the RAP80-ABRA1-BRCA1 complex and the
accumulation of 53BP1 at sites of DNA damage (Huen et al.,
2007; Kolas et al., 2007; Mailand et al., 2007; Sakasai and Tib-
betts, 2008; Wang and Elledge, 2007). RNF8 most likely facili-
tates the relocalization of these repair proteins by catalyzing
the ubiquitylation of H2A-type histones surrounding the DNA
lesion (Huen et al., 2007; Mailand et al., 2007). Because the ubiq-
uitin-binding motifs of RAP80 (UIMs) mediate BRCA1 recruit-
ment to sites of DNA lesions, it is likely that RAP80 directly binds
the products of RNF8 ubiquitylation to facilitate BRCA1-depen-
dent DSB repair. By contrast, 53BP1 does not possess ubiqui-
tin-binding domains, and its localization to DNA damage sites,
rather, depends on its Tudor domain, a methyl-lysine residue-
binding module (Botuyan et al., 2006; Huyen et al., 2004). It is,
therefore, possible that modification of chromatin by RNF8
enables the recognition of methylated histones by the 53BP1
Tudor domain. The precise function of 53BP1 and its role during
the cellular response to DNA damage is unclear, although it has
been implicated in regulating the G2/M phase checkpoint (DiTul-
lio et al., 2002; Wang et al., 2002) class switch recombination
(CSR) (Manis et al., 2004) as well as repair of DNA DSBs via
nonhomologous end-joining (NHEJ) (Difilippantonio et al., 2008).
Recently, RIDDLE (radiosensitivity, immunodeficiency, dys-
morphic features, and learning difficulties) syndrome, a novel
human immunodeficiency disorder associated with defective
DSB repair, has been described (Stewart et al., 2007). RIDDLE
syndrome shares overlapping clinical features with A-T, and cells
derived from a RIDDLE patient (15-9BI) exhibit impaired relocal-
ization of 53BP1 and BRCA1 to DSBs, while MDC1 and NBS1
remain unaffected (Stewart et al., 2007). However, efforts to
identify the gene responsible for this disorder have so far failed,
suggesting that a novel participant of the DNA damage response
is responsible for this syndrome.
Here, we report the identification of the gene mutated in
RIDDLE syndrome, RNF168, by mining an RNA interference
screen that examined 53BP1 focal accumulation at sites of
DNA damage. RNF168 itself accumulates at DSBs downstream
of RNF8 through a physical interaction with ubiquitylated H2A.
Like RNF8, RNF168 is also an E3 ubiquitin ligase that acts in
concert with UBC13 to catalyze the formation of lysine 63
(K63)-linked ubiquitin conjugates and promotes the ubiquityla-
tion of H2A-type histones surrounding the damage, thereby
amplifying, or spreading, the regulatory ubiquitylation signal initi-
ated by RNF8. In turn, RNF168-dependent ubiquitylation medi-
ates the accumulation of 53BP1 and BRCA1 at DNA lesions to
promote DSB repair, DNA damage checkpoints, and survival
following IR exposure. Our results, therefore, indicate that the
protein ubiquitylation cascade controlled by RNF8 and RNF168
is a physiologically important response to DSBs in human cells
and suggest that the RNF8/RNF168 pathway might be an impor-
tant conduit for ATM-dependent DNA damage signaling.
RESULTS
RNF168 Promotes the Accumulation of 53BP1
and BRCA1 at Sites of DNA Damage
A hallmark of RIDDLE cells is the inability of 53BP1 to relocalize
to sites of DNA double-strand breaks (Stewart et al., 2007). In theabsence of any detectable mutations in either RNF8 orUBC13 in
these cells (G.S.S., unpublished data), we reasoned that any new
gene necessary for 53BP1 focus formation would be an ideal
candidate for being mutated in the RIDDLE syndrome. There-
fore, we mined a siRNA screen that utilized 53BP1 focus forma-
tion as a readout (Figure S1 available online) (Kolas et al., 2007).
From the initial screen, we narrowed down our search to a set of
59 candidate genes that displayed a statistical reduction in
53BP1 focus formation 24 hr postirradiation (Table S1). The
contribution of each of these genes for the accumulation of
53BP1 at sites of DNAdamagewasdirectly tested in a secondary
screen. HeLa cells grown in 384-well plates were transfected
with enzymatically prepared siRNA (esiRNA), as described previ-
ously (Kolas et al., 2007), and fixed 1 hr postirradiation before
being processed for 53BP1 immunofluorescence and auto-
matedmicroscopy. The knockdown of RNF8was used as a posi-
tive control, and an esiRNA-targeting firefly luciferase was used
as a negative control. As shown in Figure 1A, the esiRNA-target-
ing RNF168 and ubiquitin (UBB) yielded a reduction in 53BP1
foci that approached that of RNF8 depletion. Given that ubiquitin
mutations were unlikely to cause RIDDLE syndrome, we focused
our attention on RNF168. To confirm that the impairment of
53BP1 localization to sites of DNA damage was, indeed, caused
by depletion of the RNF168 protein, we rescued the 53BP1 foci
phenotype by reintroduction of a siRNA-resistant epitope-
tagged RNF168 cDNA (RNF168*) (Figure 1B). Then, we raised
a polyclonal antibody against RNF168 that confirmed that both
the esiRNA and siRNA against RNF168 efficiently knocked down
protein expression (Figures 1C and S1E). From these results, we
concluded that RNF168 is critical for the accumulation, or reten-
tion, of 53BP1 at sites of DNA damage in response to IR.
Next, we addressed whether RNF168 is involved in the forma-
tion of BRCA1, NBS1, g-H2AX, MDC1, RIF1, and conjugated
ubiquitin foci after IR, following the siRNA-mediated depletion
of RNF168 in U2OS cells. We found that, in addition to promoting
53BP1 focus formation, RNF168 also promotes the accumula-
tion of BRCA1 and RIF1 at sites of DNA damage (Figures 1D
and S2). Moreover, RNF168 depletion severely impaired the
formation of conjugated ubiquitin foci as detected by the FK2
monoclonal antibody (Figures 1D and S2). In contrast, RNF168
depletion by RNAi did not adversely affect the formation of
g-H2AX, MDC1, and NBS1 IR-induced foci (Figures 1D and
S2). Therefore, we concluded that RNF168 plays an important
role in the ubiquitylation pathway that mediates 53BP1 and
BRCA1 recruitment to sites of DNA damage downstream of
MDC1. Importantly, the phenotypes imparted by RNF168 deple-
tion overlap with those observed in cells derived from the 15-9BI
RIDDLE patient. RNF168 was, therefore, considered as a prime
candidate for the gene mutated in the RIDDLE syndrome.
Biallelic Mutations in RNF168 Cause RIDDLE Syndrome
To look for RNF168mutations in 15-9BI RIDDLE cells, we ampli-
fied and sequenced the RNF168 exons from genomic DNA
(Figure 2A). Two mutations were identified. The first mutation
was a duplication of a G nucleotide at position 397 (c.397
dupG). This insertion produces a frameshifted mRNA that codes
for a protein that contains the first 132 amino acid residues of the
wild-type protein followed by 12 residues coded by the shiftedCell 136, 420–434, February 6, 2009 ª2009 Elsevier Inc. 421
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reading frame (p.Ala133GlyfsX11; A133fsX in short) (Figure 2B).
The second mutation was a deletion of nucleotides 1323–1326
(c.1323_1326 delACAA) leading to a predicted protein that
contains the first 441 wild-type residues of RNF168 followed
by 46 amino acid residues resulting from the shifted reading
frame (p.Gln442LysfsX45, referred to hereafter as Q442fsX)
(Figure 2B). Moreover, sequencing RNF168 in the parents of
15-9BI indicated that the c.397 dupG mutation originated from
the father, whereas the c.1323_1326 delACAA mutation was
transmitted by the mother (Figure 2A). The 15-9BI patient, there-
fore, contains biallelic mutations in the RNF168 gene, which are
predicted to result in aberrant RNF168 proteins. These results
strongly suggest that RIDDLE is a recessive disorder.
To determine whether the mutant RNF168 proteins are ex-
pressed in RIDDLE cells, we generated an additional antibody
directed against the N-terminal region of RNF168. This anti-
body detects endogenous RNF168 after immunoprecipitation
(Figure S3) and was used to immunoprecipitate RNF168 from
BJ human fibroblasts, RIDDLE 15-9BI cells, and 15-9BI cells
stably expressing wild-type RNF168. While we readily detected
RNF168 in BJ and 15-9BI cells expressing RNF168, in the
15-9BI cells, we failed to detect any band that would correspond
to the A133fsX or Q442fsX mutant proteins (Figure 2C). These
results indicate that, in cells derived from the 15-9BI patient,
the RNF168 mutant proteins, if expressed at all, are grossly
underexpressed relative to normal levels.
Analysis of the predicted RNF168 protein sequence sug-
gested that RNF168 might be an E3 ubiquitin ligase by virtue of
its N-terminal RING finger motif (Figure 2B). Furthermore,
RNF168 contains two ubiquitin interaction motifs, termed MIU
for ‘‘motif interacting with ubiquitin,’’ that have been shown to
selectively bind to ubiquitin chains (Penengo et al., 2006). Inter-
estingly, neither RNF168 mutations found in the 15-9BI patient
affect the RING finger motif, but both result in predicted proteins
that either lack a single (Q442fsX) or both (A133fsX) MIU motifs
(Figure 2B).
To ascertain whether the RNF168 gene is responsible for the
cellular phenotypes associated with RIDDLE syndrome, we
introduced wild-type RNF168 tagged with hemagglutinin (HA)
into 15-9BI fibroblasts via retroviral transduction (Figure 2D).
Two independent clones were selected, and their clonogenic
survival in response to IR was determined. As shown in
Figure 2E, wild-type HA-RNF168 restores radio resistance to
the 15-9BI fibroblasts. In addition, the HA-RNF168-comple-
mented cells became proficient in the accumulation of BRCA1,
53BP1, RAP80, and ubiquitin conjugates at sites of DNA damage
(Figures 2F and S4). Together, these data indicate that recessivemutations in the RNF168 gene are responsible for the cellular
defects observed in the 15-9BI patient.
DNA Damage Signaling by RNF168 Requires Its RING
and MIU Domains
The presence of a RING finger in RNF168 along with the twoMIU
motifs suggests that its putative E3 ligase activity, or its ability to
bind ubiquitin, might be important for its function in the DNA
damage response. To map the functionally relevant regions of
RNF168, we generated a set of HCT116 cell lines that express
siRNA-resistant RNF168 (wild-type or mutant) under the control
of a tetracycline-inducible promoter. First, we deleted the RING
finger (DRING) to examine the contribution of the potential E3
ligase activity of RNF168 since point mutations in the RING finger
motif resulted in proteins that were poorly expressed (data not
shown). To assess the contribution of the MIU motifs, we intro-
duced mutations that impair but do not totally abolish ubiquitin
binding (Penengo et al., 2006) singly or in combination (yielding
the A179G, A450G, and A179/A450G mutants). In addition, we
also excised the entire MIU motifs singly or in combination
(yielding the DMIU1, DMIU2, and DMIU1/2 mutants). Addition
of tetracycline (tet) to the media for 24 hr resulted in exogenous
protein expression that was roughly 3- to 5-fold higher than that
of the endogenous protein (Figure S5A).
Using these cell lines, we depleted endogenous RNF168 by
RNAi prior to tet-mediated induction. The cells were then irradi-
ated and processed for 53BP1 immunofluorescence. Utilizing
this approach, we found that the RNF168 RING finger was crit-
ical to promote the formation of 53BP1 foci (Figures 3 and
S10). Interestingly, the A179G point mutation in MIU1 did not
impair RNF168 function, whereas the MIU2 A450G and double
A179G/A450G mutation(s) progressively led to a large reduction
in the number of 53BP1 foci-positive cells following irradiation
(Figure 3). Examination of the 53BP1 focus morphology revealed
that the 53BP1 foci formed in the A179G/A450G line were mark-
edly smaller than those of wild-type cells (Figure 3B). A similar
picture emerges when 53BP1 focus formation was examined
in cells expressing RNF168 lacking one or both MIU motifs. We
found that deletion of MIU1 had little effect on the ability of cells
to form53BP1 IR-induced foci,whereasdeletionofMIU2 impaired
53BP1 focus formation to levels similar to those observed with
the A179G/A450G double mutation (Figure 3). However, in the
context of the MIU2 deletion, MIU1 nevertheless played some
function, as deletion of bothMIUs further impaired 53BP1 relocal-
ization to DSB sites to background levels (Figure 3). Therefore, we
concluded that RNF168 requires its RING finger and MIU motifs
(primarily MIU2) to promote DNA damage signaling.Figure 1. RNF168 Promotes the Accumulation of 53BP1 and BRCA1 IR-Induced Foci
(A) HeLa cells seeded in 384-well plates were transfected with the indicated esiRNA. At 24 hr posttransfection, cells were irradiated with a 10 Gy dose, fixed 1 hr
post-IR, and processed for 53BP1 immunofluorescence and quantitation as described previously (Kolas et al., 2007). The 53BP1 focus index represents the
number of 53BP1 foci detected in a confocal slice using our spot-finding algorithm. Data are represented as the mean ± SEM (n = 4).
(B) HeLa cells were transfected first with either nontargeting (siCTRL) or RNF168 (siRNF168) siRNAs. After transfection, cells were reseeded and transfected with
an empty control vector (empty) or a siRNA-resistant FLAG-tagged RNF168 expression vector (RNF168*). Twenty-four hours later, cells were irradiated with
a 10 Gy dose, fixed 1 hr post-IR, and processed for 53BP1 immunofluorescence. The upper panels display representative micrographs, and the data in the lower
panel represent the mean ± SEM (n = 3).
(C) Representative knockdown of RNF168 in HeLa cells using esiRNA. LUC, luciferase.
(D) U2OS cells transfected either with control (siCTRL) or RNF168 (siRNF168) siRNAs were either mock treated (IR) or irradiated with a 10 Gy dose (+IR). At 1 hr
post-IR, cells were fixed and processed for immunofluorescence using the indicated antibodies. Quantitation of the data can be found in Figure S2.Cell 136, 420–434, February 6, 2009 ª2009 Elsevier Inc. 423
Figure 2. RNF168 Is the Gene Mutated in the RIDDLE Syndrome
(A) Sequencing of the RNF168/RNF168 exons in cells derived from the 15-9BI RIDDLE patient and his parents.424 Cell 136, 420–434, February 6, 2009 ª2009 Elsevier Inc.
(B) Schematic structure of RNF168. The predicted mutant proteins encoded by the maternal (c.1323_1326 delACAA) and paternal (c.397 dupG) RNF168mutant
alleles are shown. The blue shaded area of the RIDDLE-associated mutant proteins marks sequences produced by the frameshifted open reading frame.
(C) Whole-cell extracts (WCE) from BJ cells, 15-9BI cells transduced with either an empty retrovirus (15-9BI) or wild-type RNF168 (15-9BI + WT), were subjected
to immunoprecipitation followed by immunoblotting with the RNF168 (N) antibody. Actin is used as loading control for the WCE.
(D) WCE from 15-9BI cells transduced with a retrovirus containing no insert (+vector) or HA-RNF168 (+RNF168; two independent clones are presented) were
separated on SDS-PAGE and subjected to HA and SMC1 immunoblotting. SMC1 is used as loading control.
(E) Clonogenic survival of the 15-9BI cells described in (D) following irradiation. Data are represented as mean ± SEM (n = 3).
(F) Control-transfected (15-9BI+vector) or RNF168-complemented (15-9BI + RNF168) RIDDLE cells were either mock treated (no IR) or irradiated with a dose of
5 Gy. Cells were fixed 1 hr post-IR and processed for 53BP1, RAP80, BRCA1, and anti-ubiquitin conjugate (FK2) immunofluorescence. Representative micro-
graphs are shown. A time course of this experiment is shown in Figure S4.RNF168 Accumulates at Sites of DNA Damage
in an MIU-Dependent Manner
The functional importance of RNF168 for the DNA damage
response prompted us to test whether RNF168 itself accumu-
lated at sites of DNA damage. We found that endogenous
RNF168 rapidly relocalized to g-H2AX-positive subnuclear foci,
as soon as 5 min after irradiation (Figure 4A). The loss of these
foci in cells transfected with RNF168 siRNA confirmed the
specificity of the antibody in immunofluorescence (Figure S6A).
The rapid accumulation of RNF168 into foci was also observed
in cells expressing green fluorescent protein (GFP)-tagged
versions of RNF168 (Figure S6B). Collectively, these observa-
tions suggest that RNF168 acts locally at the site of DNA breaks
to promote the DNA damage response.
Next, we mapped the domains of RNF168 required for its
localization to sites of DNA damage. We introduced, in the
context of GFP-RNF168, mutations that disrupted the RING
finger or MIU motifs as well as the RIDDLE syndrome mutations
described above. Wild-type RNF168 and the allelic series pre-
sented were transiently (Figures 4B and S5B) or stably
(Figure S7) transfected into HeLa and U2OS cells, respectively,
for foci analyses. Surprisingly, we found that deletion of the
RING finger (DRING) did not affect RNF168 focus formation after
IR (Figures 4B and 4C). In contrast, RNF168 accumulation at
sites of DNA damage required functional MIU motifs. Whereas
the A179G and A450G mutations individually had a minimal
impact on the ability of RNF168 to form foci, we found that the
A450G mutation in MIU2 impaired the maintenance of RNF168
at sites of DNA damage (see the 4 hr and 8 hr time points,
Figure S7). The double A179G/A450G mutation severely
impaired, but did not totally abolish, the ability of RNF168 to
form foci especially at early time points after IR (Figures 4B,
4C, and S7). This latter result was consistent with the observa-
tion that the A/Gpointmutants are not entirely null for ubiquitin
binding. We next examined the impact of MIU deletions on
RNF168 localization. Deletion of MIU1 (DMIU1) did not impair
RNF168 accumulation at sites of DNA damage (Figures 4B and
4C). In contrast, deletion of the MIU2 domain (alone or in the
context of the DMIU1/2 mutant) severely impaired the focal
redistribution of RNF168 (Figures 4B and 4C). These results indi-
cate that RNF168 localization at sites of DNA damage depends
on its MIU motifs, primarily mediated through MIU2.
Finally, we examined whether the A133fsX and Q442fsX
mutant RNF168 proteins could relocalize to DSBs. As shown in
Figure 4B, the product of neither RIDDLE allele was able to
form IR-induced foci, in line with the observation that they both
lack the MIU2 motif.H2A Ubiquitylation Mediates Accumulation of RNF168
at DNA Lesions
As a means to place RNF168 in the DNA damage signaling
cascade, we quantitated RNF168 foci in cells depleted of
MDC1, RNF8, NBS1, 53BP1, and BRCA1. As shown in
Figure 5AB, RNF168 foci are abrogated in cells depleted of
MDC1 and RNF8, whereas they are unaffected in cells depleted
of NBS1, 53BP1, and BRCA1. These observations indicate that
RNF168 acts either downstream or at the same level as RNF8
to promote DNA damage signaling. To distinguish between
these two possibilities, we examined RNF8-YFP focus formation
in RNF168-depleted cells. Strikingly, upon RNF168 depletion,
RNF8 still accumulated at DSBs (Figure 5C), strongly indicating
that RNF168 acts downstream of RNF8.
This latter result, coupled with the critical importance of the
MIUs for formation of RNF168 foci, suggested that RNF168 is re-
cruited to DNA lesions by binding to ubiquitylated substrates of
RNF8. In support of this possibility, we found that the RNF8RING
finger was necessary to promote RNF168 foci (Figures 5D and
5E and S5B). In addition, we ascertained that UBC13, proposed
to be the RNF8 E2, was also critical for RNF168 focus formation
(Figure 5F). Lastly, we took advantage of the observation that
MG132 treatment greatly reduces H2A ubiquitylation (Mailand
et al., 2007). As a consequence, MG132 inhibits the formation
of BRCA1 and 53BP1 IR-induced foci while having little or no
effect on RNF8 focus formation (Jacquemont and Taniguchi,
2007; Mailand et al., 2007). Addition of MG132 to cells prior to
irradiation profoundly inhibited the accumulation of RNF168 at
sites of DNA damage (Figure S6C). Together, these results
demonstrate that RNF168 localization at sites of DNA damage
depends on protein ubiquitylation carried out by RNF8-UBC13.
Because histones H2A and H2AX have been shown to be
targets of the RNF8-UBC13 E3 ligase activity (Huen et al.,
2007; Mailand et al., 2007), we therefore examined whether
RNF168, via its MIUs, can physically interact with ubiquitylated
H2A (uH2A). We transfected FLAG-RNF168 (wild-type or MIU
deletion mutants) into HEK293 T cells and prepared chromatin-
enriched fractions that were subjected to FLAG immunoprecip-
itation. As shown in Figure 6A, wild-type RNF168 interacts with
uH2A, in particular the diubiquitylated form. This interaction is
slightly reduced in the DMIU1 mutant but is abolished by the
DMIU2 or DMIU1/2 mutations. Remarkably, the requirement for
the MIU2 motif for the RNF168-uH2A interaction mirrors the
requirement for formation of RNF168 IR-induced foci. Next, we
examined whether this interaction was dependent on DNA
damage and RNF8. As expected, we observed that the RNF168-
uH2A interaction is stimulated by DNA damage and is greatlyCell 136, 420–434, February 6, 2009 ª2009 Elsevier Inc. 425
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The functional importance of the RNF168 RING finger prompted
us to examine whether RNF168 is a bona fide E3 ubiquitin ligase.
We expressed full-length RNF168, as well as the C19S and
DRING mutants, as recombinant GST fusion proteins in bacteria
(Figure S9A). We then assembled in vitro ubiquitylation reactions
in which the RNF168 proteins were added to a panel of E2
enzymes (UBC1, UBC3, UBC7, and UBC13/MMS2) in addition
to the E1 (UBE1), ATP, and ubiquitin. Protein ubiquitylation was
assessed by immunoblotting using the FK2 antibody to detect
conjugated ubiquitin. As shown in Figure 6D, RNF168 robustly
autoubiquitylates when reactions are carried out in the presence
of the UBC13-MMS2 complex, but not with any other E2 enzyme
tested. Furthermore, this autoubiquitylation activity of RNF168
requires a functional RING finger since the C19S mutation or
deletion of the RING finger completely abolished ubiquitin conju-
gation (Figure 6D). Identical results were obtained when RNF168
immunopurified from HEK293 T cells was used in similar ubiqui-
tylation assays (Figure S9B). We also examined whether the E3
activity of RNF168 was affected by the MIU point mutations or
the RIDDLE syndrome mutations. Predictably, these mutants
displayed normal levels of E3 ligase activity since they do not
impact the RING finger (Figure S9C).
The notion that UBC13 acts as the RNF168 E2 is significant
given the importance of UBC13 in orchestrating the response
to IR. To further explore this relationship, we tested whether
UBC13 and RNF168 interact together using coimmunoprecipita-
tion studies. We detected an interaction of either endogenous
(Figure 6E) or epitope-tagged RNF168 (Figure S9D) with UBC13
that was dependent on its RING finger domain. RNF168 is, there-
fore, an E3 ubiquitin ligase that utilizes UBC13 as its E2.
Next, we sought to determine what type of ubiquitylation
linkage is catalyzed by RNF168-UBC13. Initially, we carried out
in vitro ubiquitylation assays in which different ubiquitin lysine
mutants were used. We found that RNF168 generates ubiquitin
conjugates with wild-type, K6R, and K48R ubiquitin, but not
with the K63R ubiquitin mutant or a ubiquitin version that lacks
all lysine residues (K0) (Figure 6F). These results indicate that
RNF168, in the presence of UBC13, catalyzes K63-linked polyu-
biquitin (UbK63) chains, a result confirmed when the products of
the above reactions were probed with an anti-UbK63 antibody
(Figure 6F).
To determine whether RNF168 is also necessary for the forma-
tion of K63-linked ubiquitin conjugates in vivo, we took advan-
tage of novel human monoclonal antibodies directed against
K48 (UbK48) or UbK63 chains (Newton et al., 2008). These anti-
bodies were used in immunofluorescence experiments to deter-
mine what type of ubiquitin conjugation occurred at sites of DNA
damage. As shown in Figures 6G and S10, UbK63 (but not
UbK48; data not shown) were detected in IR-induced foci that
colocalize with g-H2AX. Not surprisingly, the formation of
UbK63 chains was entirely dependent on UBC13, the only E2
known to catalyze such chain linkage (Figure 6G). Importantly,
depletion of RNF8 or RNF168 strongly impaired formation of
UbK63 foci, consistent with these enzymes acting with UBC13
at sites of DNA damage. Moreover, deletion of the RNF168
RING finger abolished the formation of UbK63 foci (Figure S10),
indicating that the E3 ligase activity of RNF168 is necessary toreduced in cells treated with RNF8 siRNA (Figures 6B and 6C).
These results suggest that RNF8-dependent H2A ubiquitylation
mediates the accumulation of RNF168 at sites of DNA damage.
Figure 3. RNF168 Function Requires Its RING and MIU Motifs
(A–C) Flp-In/T-Rex HCT116 cell lines expressing the indicated RNF168
mutants under a tetracycline-inducible promoter were seeded into 10 cm
dishes and transfected with nontargeting (CTRL) or RNF168 siRNA. Cells
were then reseeded onto coverslips (for immunofluorescence) and in 6 cm
dishes to analyze protein expression. RNF168 expression was induced for
24 hr as described in the Experimental Procedures. Cells were then irradiated
(10 Gy) and fixed 1 hr post-IR to be processed for immunofluorescence (B),
quantitation of 53BP1 foci (A), and immunoblotting (C). Data in (A) are repre-
sented as the mean ± SEM (n = 4).
Figure 4. RNF168 Accumulates at Sites of DNA Damage
(A) U2OS cells were either irradiated with a 10 Gy dose or mock treated (IR). After the indicated time points, cells were fixed and processed for RNF168 and
g-H2AX immunofluorescence. DNA was stained with DAPI.
(B) HeLa cells transfected with the indicated GFP-RNF168 expression vectors were irradiated with a 5 Gy IR dose. At the indicated time points, cells were fixed
and processed for GFP fluorescence and g-H2AX immunofluorescence. DNA was stained with DAPI.
(C) Quantitation of (B). Data are represented as the mean ± SD (n = 3).RNF168 Targets H2A-Type Histones
Ubiquitylated H2A can be detected in IR-induced foci that coloc-
alize with g-H2AX (Nicassio et al., 2007). Therefore, we examined
whether formation of uH2A foci was dependent on RNF8,
RNF168, or UBC13. To our surprise, we found that the formationbuild UbK63 at DNA damage sites. Lastly, depletion of 53BP1
and especially BRCA1, another E3 ligase, did not impair the
formation ofK63-linked ubiquitin conjugates atDSBs (Figure 6G).
These results indicate that RNF168 catalyzes K63-linked ubiqui-
tylation on the chromatin that surrounds DNA lesions.Cell 136, 420–434, February 6, 2009 ª2009 Elsevier Inc. 427
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Figure 5. RNF168 Acts Downstream of RNF8
(A) U2OS cells transfected either with control (siCTRL) or the indicated siRNAs were irradiated with a 10 Gy dose. At 1 hr after irradiation, cells were fixed and
processed for RNF168 and g-H2AX immunofluorescence. Controls for the effectiveness of the siRNAs used in this experiment can be found in Figure S8.
(B) Quantitation of RNF168 foci from the experiment described in (A). Data are represented as the mean ± SD (n = 3).
(C) U2OS cells stably transfected with YFP-RNF8 were transfected either with control (siCTRL), MDC1 (siMDC1), or RNF168 (siRNF168) siRNAs. At 36 hr post-
transfection, cells were either mock treated (IR) or X irradiated with a 10 Gy dose (+IR). At 1 hr after irradiation, cells were fixed and processed for YFP and
g-H2AX immunofluorescence. DNA was stained with DAPI. Scale bar, 16 mm.
(D) HeLa cells were transfected first with either nontargeting control (CTRL) or RNF8 (RNF8) siRNAs. After transfection, cells were reseeded onto coverslips and
transfected either with an empty control vector (empty) or murine FLAG-RNF8 vectors (mRNF8 or mRNF8 DRING). Murine RNF8 mRNA is resistant to a human
siRNA pool against RNF8 (Kolas et al., 2007). At 24 hr after plasmid transfections, cells were irradiated with a 10 Gy dose, fixed 1 hr post-IR, and processed for
RNF168 immunofluorescence. Refer to Figure S5C for control immunoblots.
(E) Quantitation of RNF168 foci from the experiment described in (D). Data are represented as the mean ± SD (n = 3).
(F) U2OS cells transfected either with control (siCTRL) or UBC13 siRNAswere irradiated with a 10 Gy dose. At 4 hr after irradiation, cells were fixed and processed
for RNF168, g-H2AX, and conjugated ubiquitin (FK2) immunofluorescence. The percentage of cells in the population that display the represented phenotype is
indicated on the micrograph.of uH2A foci was not only dependent on RNF8-UBC13, but was
also dependent on the presence of RNF168 (Figure 7A). Forma-
tion of uH2A foci was independent of BRCA1 and 53BP1,
pointing to RNF168 as being critical for the generation of uH2A
IR-induced foci. Importantly, cells expressing the RNF168
DRING were unable to support uH2A foci formation, arguing
against the possibility that the physical binding of RNF168 to
uH2A decreased its removal from chromatin (Figure S10). H2A-
type histones might, therefore, be targeted in vivo by both
RNF8 and RNF168.
The above results suggest that RNF168 and RNF8 have over-
lapping sets of substrates. However, another possibility might be
that RNF168 is necessary for RNF8 action at sites of DNA
damage. To distinguish between these possibilities, we exam-
ined whether RNF168 overexpression in RNF8-depleted cells
restored 53BP1 focus formation. As shown in Figures 7B and
S5D, overexpression of wild-type RNF168 indeed restored
53BP1 focus formation in more than 50% of the RNF8-depleted
cells. Together, these results support a model whereby RNF168
and RNF8 have overlapping substrates and RNF168 lies down-
stream of RNF8.
Next, we directly tested whether RNF168 can ubiquitylate H2A
in E3 ligase reactions in which either recombinant H2A or H2B
was added to RNF168-UBC13. We observed that H2A, not
H2B, is specifically ubiquitylated by RNF168 (Figure 7C),
strongly supporting the possibility that H2A-type histones are
RNF168 substrates.
Finally, to gain direct evidence that RNF168 catalyzes the
formation of ubiquitylated H2A, we examined the ubiquitylation
status of H2A in response to DNAdamage (Huen et al., 2007).We
isolated bulk histones by acid extraction of irradiated HeLa
cells transfected with control or RNF168 siRNAs. As shown in
Figure 7D, we observed that RNF168 depletion reduces the
levels of radiation-induced histone H2A ubiquitylation, in partic-
ular the diubiquitylated form. We conclude that RNF168 can
catalyze the ubiquitylation of H2A-type histones in response to
DNA damage.
DISCUSSION
We report that mutations in RNF168 are responsible for RIDDLE
syndrome. RNF168 depletion impairs the accumulation of
53BP1 and BRCA1 at sites of DNA lesions and impacts boththe S and G2/M checkpoints (K.T., S.P., D.D., and G.S.S.,
unpublished data). Although it is unclear which aspects of
RNF168 deficiency contribute to the syndrome phenotype, we
speculate that, given the known function of 53BP1 in promoting
DSB repair during CSR, it is the failure of 53BP1 to be relocalized
during this process that is the underlying cause of the immuno-
deficiency in this patient. Although we previously failed to detect
any gross defects in NHEJ in RIDDLE cells (Stewart et al., 2007),
the recent demonstration of a role for 53BP1 in promoting
nonclassical NHEJ during V(D)J recombination (Difilippantonio
et al., 2008) suggests that RNF168 may act to organize the chro-
matin to facilitate long-range NHEJ.
The Action of RNF8 and RNF168 at Sites of DNADamage
RNF8, RNF168, and BRCA1 define an emerging regulatory ubiq-
uitylation cascade initiated by DSBs. Our observation that RNF8
and RNF168 are sequentially recruited to DNA lesions strongly
suggests that they act successively, possibly by ubiquitylating
separate substrates (Figure 7E). However, we also report
evidence that RNF168 amplifies RNF8-dependent H2A ubiquity-
lation. With respect to H2A ubiquitylation, RNF8 acts primarily to
increase the local concentration of RNF168 at sites of DNA
damage by initiating the ubiquitylation of H2A-type histones,
which then act as a signal to physically recruit RNF168 via its
MIU motifs to the sites of DNA damage (Figure 7E). In support
of this model, in an accompanying paper, Doil et al. also describe
the identification of RNF168 and propose a similar model of
RNF168 action at sites of DNA damage (Doil et al., 2009 [this
issue of Cell]). The cooperation of RNF8 and RNF168 to ubiqui-
tylate histones as a means to reorganize chromatin is not
a unique phenomenon because H2A and H2B ubiquitylation
during transcriptional regulation also requires the action of two
E3 ligases, Ring1a and Ring1b (for H2A) and RNF20 and
RNF40 (for H2B) (Wang et al., 2004; Zhu et al., 2005).
The availability of novel antibodies against K63-linked ubiqui-
tin chains (Newton et al., 2008) has allowed us to demonstrate
that RNF168 promotes the formation of K63-linked ubiquitin
conjugates at sites of DNA damage. However, at this stage,
we have been unable to provide in vivo evidence that UbK63
chains are assembled on H2A or H2AX. Given that K63-linked
ubiquitylation clearly plays an important role during the organiza-
tion of the DNA damage response (Sobhian et al., 2007), the
identification of additional targets of RNF8 and RNF168,Cell 136, 420–434, February 6, 2009 ª2009 Elsevier Inc. 429
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Figure 6. RNF168 Binds to uH2A and Is a UBC13-Dependent E3 Ligase
(A) HEK293 T cells transfected with the indicated FLAG-RNF168 vectors were irradiated (20 Gy), and chromatin-enriched extracts (CEE) were prepared 4 hr
post-IR. (Upper panel) CEE were subjected to FLAG immunoprecipitation and then separated on SDS-PAGE and subjected to FLAG, ubiquitylated (uH2A), or
total H2A (H2A) immunoblotting. (Lower panel) CEE were probed with the same antibodies as above. The diubiquitylated H2A band is shown for the uH2A blot.
(B) HEK293 T transfected with FLAG-RNF168 were irradiated with a 20 Gy dose (+IR) or left untreated (IR). At 4 hr postirradiation, CEE were prepared and sub-
jected to FLAG immunoprecipitation. Precipitates were separated on SDS-PAGE and subjected to FLAG and ubiquitylated (uH2A) immunoblotting.
(C) HEK293 T cells were first transfected with nontargeting control (siCTRL) or RNF8 (siRNF8) siRNAs. Cells were then transfected with the indicated FLAG-
RNF168 expression constructs and irradiated (20 Gy), and CEE were prepared 4 hr post-IR. (Upper panel) The extracts were subjected to FLAG immunoprecip-
itation, separated on SDS-PAGE, and immunoblotted with antibodies to FLAG, uH2A, or H2A. (Lower panel) CEE were probed with the indicated antibodies.
(D) In vitro ubiquitylation assays employing recombinant GST-RNF168 proteins were assembled as described in the Experimental Procedures. The reaction prod-
ucts were analyzed by immunoblotting with anti-ubiquitin conjugate (FK2) and anti-RNF168 antibodies.
(E) HEK293 T WCE were subjected to UBC13 immunoprecipitation (IP). The immunoprecipitates were separated on SDS-PAGE and subjected to UBC13 and
RNF168 immunoblotting.
(F) In vitro ubiquitylation assays using recombinant GST-RNF168 proteins were assembled in the presence of wild-type or the indicated mutated ubiquitin
proteins. The reaction was analyzed by immunoblotting with ubiquitin conjugate (FK2) (upper-left panel), RNF168 (lower-left panel), and UbK63 antibodies (right
panel).
(G) U2OS cells transfected either with control (siCTRL) or the indicated siRNAs were irradiated with a 10 Gy dose. At 4 hr after irradiation, cells were fixed and
processed for K63-linked ubiquitin chain (UbK63) and g-H2AX immunofluorescence. Controls for the effectiveness of the siRNAs can be found in Figure S8. DNA
was counterstained with DAPI.
(H) Quantitation of UbK63 foci from the experiment described in (G). Foci-positive cells were defined as cells with more than ten defined UbK63 foci. Data are
represented as the mean ± SD (n = 3).Generation of a siRNA-Resistant Flag-RNF168-Expressing Vector
To generate RNF168 constructs resistant to RNF168 siRNA#4 from Dharma-
con (D-007152-04), we introduced the following underlined silent mutations
in RNF168: 50-GAGGAGTCGTGTTTATTGA-30.
Antibodies
We employed the following antibodies: 53BP1 (clone 19, BD Biosciences;
NB100-305, Novus Biologicals), MDC1 (clone MDC1-50, Sigma-Aldrich;
AbD, Serotec), g-H2AX (clone JBW301, Upstate), BRCA1 (clonesMS110, Cal-
biochem; D9, Santa Cruz), RAP80 (Bethyl Laboratories), histone H3 phospho-
serine 10 (clone 6G3, Cell Signaling Technologies), conjugated ubiquitin (clone
FK2, Stressgen), UbK63 (clone Apu3.A8, Genentech), UbK48 (clone Apu2.07,
Genentech), UbK63 (clone HWA4C4, Biomol International), RNF8 (gift of J.
Chen), uH2A (clone E6C5, Upstate), uH2B (clone NRO3, Me´dimabs), GST
(clone B4, Santa Cruz), Nbs1 (Novus Biologicals), RIF1 (Bethyl Laboratories),
FLAG (M2, Sigma), actin (clone JLA20, Calbiochem), HA (clone 12CA5), and
UBC13 (clone 4E11, Zymed). The RNF168 polyclonal antibodies were raised
against GST-RNF1681–200 (antibody N) and GST-RNF168380–571 (antibody C)
fusion proteins and were affinity purified.
E3 Ubiquitin Ligase Assays
Ubiquitin ligase assays were performed as follows. Assays were set up in
a total volume of 25 ml in 50 mMTris-HCl (pH 8.0) and 1mMDTT. Recombinant
GST-RNF168 (0.2 mM) was added to 0.4 mM of the indicated E2 enzymes
(Boston Biochem), 0.0125 mM E1 and 16 mM ubiquitin (Boston Biochem).
Reactions were initiated by the addition of ATP (2 mM) and MgCl2 (5 mM).
SUPPLEMENTAL DATA
The Supplemental Data include Supplemental Experimental Procedures, ten
figures, and one table and can be found with this article online at http://
www.cell.com/supplemental/S0092-8674(09)00005-1.
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how this novel protein ubiquitylation pathway promotes DNA
repair, checkpoint signaling, and the developmental processes
associated with the DNA damage response.
Finally, we expect that the discovery of RNF168will lead to the
identification of additional RIDDLE patients and that those will,
in turn, result in a better definition of the clinical phenotype of
RIDDLE syndrome. It is still unclear whether RIDDLE syndrome
is associated with genome instability or increased tumor inci-
dence. Given that RNF168 promotes the accumulation of
BRCA1 to sites of DNA damage and is likely to function in
CSR-associated DNA repair, a process tightly linked with the
development of lymphoid malignancies, it is conceivable that
RNF168 might act as a tumor suppressor gene and play a role
in the development of sporadic malignancies, particularly those
of lymphoid origin. In this respect, it might be of significance that
the father of the RIDDLE patient has developed B cell chronic
lymphocytic leukemia. Therefore, one of the important future
challenges will be to determine whether RNF168 acts as a tumor
suppressor gene.
EXPERIMENTAL PROCEDURES
Cell Culture and Plasmid Transfection
U-2-OS (U2OS) cells were cultured in McCoy’s medium, and HeLa and
HEK293 T cells were cultured in DMEM. The 15-9BI cells were cultured as
described in Stewart et al. (2007). Stable and transient transfections were per-
formed using Effectene (QIAGEN) or Lipofectamine 2000 (Invitrogen), respec-
tively, following the manufacturer’s protocol.
Quantitation of 53BP1 Foci by High-Content Microscopy
Cell imaging using the Opera system (PerkinElmer) and image segmentation
using Acapella software (PerkinElmer) were performed exactly as described
in Kolas et al. (2007).
RNA Interference
All siRNAs employed in this study were SMARTpools (ThermoFisher) or indi-
vidual siRNAs deconvolved from the SMARTpool. esiRNAs were produced
exactly as described in Kittler et al. (2005). All RNAi transfections were per-
formed using Dharmafect 1 (ThermoFisher) or Oligofectamine (Invitrogen).Cell 136, 420–434, February 6, 2009 ª2009 Elsevier Inc. 431
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(A) U2OS cells transfected either with control (siCTRL) or the indicated siRNAs were irradiated with a 10 Gy dose. At 4 hr after irradiation, cells were fixed and
processed for ubiquitylated H2A (uH2A) and g-H2AX immunofluorescence. Controls for the effectiveness of the siRNAs can be found in Figure S8. DNA was
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diation to be processed for 53BP1 immunofluorescence. DNA was counterstained with DAPI. (Upper panel) Representative micrographs. (Bottom graph) Quan-
titation of 53BP1 foci from the experiment. Data are represented as the mean ± SD (n = 3). Control immunoblots are shown in Figure S5D.
(C) Ubiquitylation assays employing the indicated GST-RNF168 proteins were assembled with either H2A (upper panel) or H2B (lower panel) as substrates. The
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(D) HeLa cells were first transfected with control (siCTRL) or RNF168 (siRNF168) siRNAs. At 36 hr after transfection, cells were irradiated with a 10 Gy dose and
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